Literature DB >> 8332082

Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2.

P Liu1, J Siciliano, B White, R Legerski, D Callen, S Reeders, M J Siciliano, L H Thompson.   

Abstract

Mitomycin C (MMC)-resistant interspecific somatic cell hybrids made between human cells and the MMC-sensitive, Chinese hamster ovary (CHO) excision repair-deficient UV41 cells generally contained human chromosome 16, while other human chromosomes were randomly present. MMC-sensitive and -resistant subclones were isolated from resistant clones, and resistance generally segregated concordantly with human chromosome 16 markers. UV radiation survival analysis of subclones indicated that MMC and UV resistance were correlated. Therefore, the complementing gene, Excision Repair Cross Complementing 4 (ERCC4), was assigned to human chromosome 16. Complementation of UV41 by human cells derived from patients with xeroderma pigmentosum groups A, C, D and F excluded ERCC4 from involvement in those disease syndromes. Resistant hybrids containing only portions of chromosome 16 were identified by the lack of concordance of multiple chromosome 16 markers. When such hybrids were used as a source of probe for fluorescent in situ hybridization onto normal human metaphases, the only region of chromosome 16 identified as being consistently present was 16p13.1-p13.3. Genetic marker analysis of informative hybrids with mapped probes refined the position of ERCC4 to 16p13.13-p13.2 and allowed the following order of markers within the region to be established: pter--(PRM1, D16S215)-D16S213-D16S53-(D16S214,ERCC4) -D16S3-D16S96-cen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332082     DOI: 10.1093/mutage/8.3.199

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

1.  ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs.

Authors:  K W Brookman; J E Lamerdin; M P Thelen; M Hwang; J T Reardon; A Sancar; Z Q Zhou; C A Walter; C N Parris; L H Thompson
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

2.  Molecular cloning of the human nucleotide-excision-repair gene ERCC4.

Authors:  L H Thompson; K W Brookman; C A Weber; E P Salazar; J T Reardon; A Sancar; Z Deng; M J Siciliano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

Review 3.  The ERCC1 and ERCC4 (XPF) genes and gene products.

Authors:  Mandira Manandhar; Karen S Boulware; Richard D Wood
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

4.  Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing.

Authors:  Laura J Smith; Jason Wright; Gabriella Clark; Taihra Ul-Hasan; Xiangyang Jin; Abigail Fong; Manasa Chandra; Thia St Martin; Hillard Rubin; David Knowlton; Jeff L Ellsworth; Yuman Fong; Kamehameha K Wong; Saswati Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-17       Impact factor: 11.205

Review 5.  Association between XPF polymorphisms and cancer risk: a meta-analysis.

Authors:  Ting-Yan Shi; Jing He; Li-Xin Qiu; Mei-Ling Zhu; Meng-Yun Wang; Xiao-Yan Zhou; Jiali Han; Hongpin Yu; Rong-Yu Zang; Qingyi Wei
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

6.  Association between nucleotide excision repair gene polymorphism and colorectal cancer risk.

Authors:  Yujie Zhang; Shenshen Wu; Xiumei Zhou; Fang Huang; Rui Chen; Yigang Wang; Jiong Wu
Journal:  J Clin Lab Anal       Date:  2019-09-30       Impact factor: 2.352

7.  Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence.

Authors:  Chunjian Zuo; Xiaolong Lv; Tianyu Liu; Lei Yang; Zelin Yang; Cao Yu; Huanwen Chen
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.